590 filings
Page 13 of 30
8-K/A
s97zq0hof
12 Jun 20
Financial Statements and Exhibits
4:31pm
CORRESP
gtk457yoebfafklqk3w
12 Jun 20
Correspondence with SEC
12:00am
UPLOAD
oattc i5x
11 Jun 20
Letter from SEC
12:00am
UPLOAD
gu8utklt daqy
3 Jun 20
Letter from SEC
12:00am
DEFA14A
0ca iiyv7pvl0l5q
2 Jun 20
Additional proxy soliciting materials
7:30am
8-K
p2h3uxy85ir
27 May 20
Other Events
4:31pm
D
e5iwgo
15 May 20
$22.57M in equity / options, sold $22.57M, 149 investors
1:22pm
CORRESP
ifdy4m9b9imc
15 May 20
Correspondence with SEC
12:00am
SC 13D
dvoodi91ua vk5o
14 May 20
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
5:25pm
UPLOAD
15lqw a8f1rvbnmer2
13 May 20
Letter from SEC
12:00am
8-K
yeikjgyoz5 h1h3
11 May 20
9 Meters Biopharma, Inc Receives Thorough QT Study Waiver by FDA for Larazotide Being Studied for Celiac Disease
4:36pm
8-K
e9cq7it5
8 May 20
9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition
4:15pm
8-K
890fp8 9qc
5 May 20
9 Meters Biopharma Hosting Research & Development Day
4:33pm
4
cdjwwzox760v
5 May 20
Change in insider ownership
4:20pm
4
r0b1lphrk1vo9v4
5 May 20
INNOVATE BIOPHARMACEUTICALS / Nissim Darvish ownership change
4:18pm
4
i12qwcns0ke
4 May 20
INNOVATE BIOPHARMACEUTICALS / Nissim Darvish ownership change
7:40pm